Literature DB >> 24807559

Expression of the iron hormone hepcidin distinguishes different types of anemia in African children.

Sant-Rayn Pasricha1, Sarah H Atkinson, Andrew E Armitage, Shivani Khandwala, Jacobien Veenemans, Sharon E Cox, Lucy A Eddowes, Theodore Hayes, Conor P Doherty, Ayse Y Demir, Edwin Tijhaar, Hans Verhoef, Andrew M Prentice, Hal Drakesmith.   

Abstract

Childhood anemia is a major global health problem resulting from multiple causes. Iron supplementation addresses iron deficiency anemia but is undesirable for other types of anemia and may exacerbate infections. The peptide hormone hepcidin governs iron absorption; hepcidin transcription is mediated by iron, inflammation, and erythropoietic signals. However, the behavior of hepcidin in populations where anemia is prevalent is not well established. We show that hepcidin measurements in 1313 African children from The Gambia and Tanzania (samples taken in 2001 and 2008, respectively) could be used to identify iron deficiency anemia. A retrospective secondary analysis of published data from 25 Gambian children with either postmalarial or nonmalarial anemia demonstrated that hepcidin measurements identified individuals who incorporated >20% oral iron into their erythrocytes. Modeling showed that this sensitivity of hepcidin expression at the population level could potentially enable simple groupings of individuals with anemia into iron-responsive and non-iron-responsive subtypes and hence could guide iron supplementation for those who would most benefit.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24807559     DOI: 10.1126/scitranslmed.3008249

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  45 in total

1.  Assessment of iron deficiency.

Authors:  Chaim Hershko
Journal:  Haematologica       Date:  2018-11-30       Impact factor: 9.941

Review 2.  Perspective: What Makes It So Difficult to Mitigate Worldwide Anemia Prevalence?

Authors:  Klaus Schümann; Noel W Solomons
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

3.  Iron replacement therapy: entering the new era without misconceptions, but more research is needed.

Authors:  Domenico Girelli; Giacomo Marchi; Fabiana Busti
Journal:  Blood Transfus       Date:  2017-09       Impact factor: 3.443

Review 4.  Biomarkers of Nutrition for Development (BOND)-Iron Review.

Authors:  Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten
Journal:  J Nutr       Date:  2018-06-01       Impact factor: 4.798

5.  Clinical Immunoassay for Human Hepcidin Predicts Iron Deficiency in First-Time Blood Donors.

Authors:  Patrick Gutschow; Huiling Han; Gordana Olbina; Keith Westerman; Elizabeta Nemeth; Tomas Ganz; Karen Copeland; Mark Westerman; Vaughn Ostland
Journal:  J Appl Lab Med       Date:  2020-09-01

Review 6.  Vitamin D and anemia: insights into an emerging association.

Authors:  Ellen M Smith; Vin Tangpricha
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-12       Impact factor: 3.243

Review 7.  Serum ferritin as an indicator of iron status: what do we need to know?

Authors:  Jahnavi Daru; Katherine Colman; Simon J Stanworth; Barbara De La Salle; Erica M Wood; Sant-Rayn Pasricha
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

Review 8.  Hepcidin regulation in the anemia of inflammation.

Authors:  Chia-Yu Wang; Jodie L Babitt
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

9.  Comparison of iron status 28 d after provision of antimalarial treatment with iron therapy compared with antimalarial treatment alone in Ugandan children with severe malaria.

Authors:  Sarah E Cusick; Robert O Opoka; Andrew S Ssemata; Michael K Georgieff; Chandy C John
Journal:  Am J Clin Nutr       Date:  2016-02-03       Impact factor: 7.045

Review 10.  Hepcidin in the diagnosis of iron disorders.

Authors:  Domenico Girelli; Elizabeta Nemeth; Dorine W Swinkels
Journal:  Blood       Date:  2016-04-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.